This document discusses neonatal anemia and jaundice. It covers topics like the pathophysiology, diagnosis, prevention and treatment of neonatal anemia. It also discusses hyperbilirubinemia in neonates, the various types and causes. The document examines hemolytic diseases in neonates including ABO and Rh incompatibility. It provides information on diagnostic approaches and the management of conditions like iron deficiency anemia and jaundice in newborns.
This document discusses neonatal anemia and jaundice. It covers topics like the pathophysiology, diagnosis, prevention and treatment of neonatal anemia. It also discusses hyperbilirubinemia in neonates, the various types and causes. The document examines hemolytic diseases in neonates including ABO and Rh incompatibility. It provides information on diagnostic approaches and the management of conditions like iron deficiency anemia and jaundice in newborns.
This document discusses neonatal anemia and jaundice. It covers topics like the pathophysiology, diagnosis, prevention and treatment of neonatal anemia. It also discusses hyperbilirubinemia in neonates, the various types and causes. The document examines hemolytic diseases in neonates including ABO and Rh incompatibility. It provides information on diagnostic approaches and the management of conditions like iron deficiency anemia and jaundice in newborns.
neonate. Seminars in Fetal and Neonatal Medicine. 2016;21(1):2-9. 2. Aher S, Malwatkar K, Kadam S. Neonatal anemia. Seminars in Fetal and Neonatal Medicine. 2008;13(4):239-47.1. 3. Widness JA. Pathophysiology , Diagnosis , and Prevention of Neonatal Anemia. 2019;1(4). 4. Nelson WE, Behrman RE, Kliegman R, Arvin AM. No Title. 15,vol 2. (Wahab SaA, Noerhayati, Soebono H, eds.). Philadelphia: W.B Saunders COmpany; 2000. 5. Infants P. Neonatal Anemia. 2017:31-36. 6. Milk-Alkali Syndrome. 2009;90033(March):261-267. 7. Maisels MJ, Maisels MJ. Downloaded from http://pedsinreview.aappublications.org by J Michael Coleman on June 4, 2010. 2010. doi:10.1542/pir.27-12-443 8. Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in Neonates : Types , Causes , Clinical Examinations , Preventive Measures and Treatments : A Narrative Review Article. 2016;45(5):558-568. 9. Zakaria Z, Abd Jalil J, Sarkawi S, et al. A Short Review on Kramel ’ s Rule and Magnetic Induction Spectroscopy. J Teknol. 2015;73(6):103-106. doi:10.11113/jt.v73.4426 10. Cohen RS, Wong RJ, Stevenson DK. Understanding Neonatal Jaundice : A Perspective on Causation. Pediatr Neonatol. 2010;51(3):143-148. doi:10.1016/S1875-9572(10)60027-7 11. Patel AS, Desai DA, Patel AR. Association of ABO and Rh incompatibility with neonatal hyperbilirubinaemia. 2017;6(4):1368-1375. 12. Cohoon R, Donne AD, Whiteway S, Carr N. Early Severe Jaundice in a Term Infant. NeoReviews 2018;19:e546. 13. Ives NK. Management of neonatal jaundice. Paediatr Child Heal (United Kingdom) 2015;25(6):276-281. 14. Singh H, Ahmed A, Gopalkrishna P V. Approach to Hyperbilirubinemia in Near Term Infants. International Journal of Contemporary Medical Research 2016;3(6):1629-1633. 15. Noronha SA. Acquired and Congenital Hemolytic Anemia. Pediatrics in Review 2016;37(6):235-245. 16. Ruiz EF, Cervantes MA. Diagnostic approach to hemolytic anemias in the adult. rev bras hematol hemoter 2015;37(6):423–425. 17. Dean L. Blood Groups and Red Cell Antigens. National Center for Biotechnology Information 2005. 18. Dharmayani D, Gatot D, Rohsiswatmo R, Tridjaja B. Serological profile and hemolytic disease in term neonates with ABO incompatibility. Paediatrica Indonesiana. 2009;49(4):219-223. 19. Drabik-clary K, Reddy VVB, Benjamin WH, Boctor FN. Case Report : Severe Hemolytic Disease of the Newborn in a Group B African-American Infant Delivered by a Group O Mother. Annals of Clinical & Laboratory Science 2006;36(2):205-207. 20. Murray NA, Roberts IAG. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2007 92: F83-F88 21. Kattimani VS, Ushakiran CB, Vs K, Contemp IJ, Mar P. Hemolytic disease of the new-born due to ABO incompatibility. Int J Contemp Pediatr 2018;5(2):605-611. 22. Yaish HM, Christensen RD, Lemons RS. Neonatal nonimmune hemolytic anemia. Curr Opin Pediatr 2017;29(1):12-19. 23. Tüysüz G, Özdemir GN, Celkan T. An infant with chronic hemolytic anemia. Türk Ped Arş 2014:264-268. 24. Frank JE. Diagnosis and Management of G6PD Deficiency Am Fam Phy 2005;72(7):1277-1282. 25. Jain R, Resident S, Jose B, et al. Blood and blood component therapy in neonates. AIIMS-NICU Protocol 2008:1-13. 26. Russel S, Miller M, Kuller M, Jeffrey A. Definition of term pregnancy. Am Coll Obstet Gynecol. 2017;130(720):164-167. 27. Pembantjanawati E, Rosita L, Cell R. Hubungan antara Indeks Produksi Retikulosit ( IPR ) dengan Red Blood Cell Distribution Width ( RDW ) pada Klasifikasi Anemia berdasarkan Defek Fungsional Correlation of Reticulocyte Production Index ( RPI ) and Red Blood Cell Distribution Width ( RDW ) on Anemia Classification based on Functional Defect. Jurnal Kedokteran Yarsi 2007;16(1):63-71. 28. Jea S, Kim S, Choi BM, Lee JH, Lee KC, Woo C. A Pediatric Case of Autoimmune Hemolytic Anemia followed by Excessive Thrombocytosis and Leukocytosis. Korean J Hematol 2007;42(3):288-291. 29. Dan K. Thrombocytosis in Iron Deficiency Anemia. Internal Medicine 2005;44(10):1025-1026. 30. Nwogoh B, Transfusion B, State E, Transfusion B, State R. PERIPHERAL BLOOD FILM - A REVIEW. 2014;12(2):71-79. 31. Constantino BT, Cogionis B, Services D, Health M. Nucleated RBCs — Significance in the Peripheral Blood Film. 32. Rosida A. Pemeriksaan laboratorium penyakit hati. :123-131. 33. Moerschel SK, Cianciaruso LB, Tracy LR, et al. A Practical Approach to Neonatal Jaundice. 2008. 34. Scope B. C-reactive protein concentrations as a marker of inflammation or infection for interpreting biomarkers of micronutrient status. :3-6. 35. Kotze MJ, Velden DP Van, Rensburg SJ Van, Erasmus R. P ATHOGENIC MECHANISMS UNDERLYING IRON DEFICIENCY AND IRON OVERLOAD : N EW INSIGHTS FOR CLINICAL APPLICATION. 20:108-123. 36. Northrop-Clewes CA, Thurham, DI. Biomarkers for the differentiation of anemia and their clinical usefulness. Journal of Blood Medicine 2013:4 11– 22.